Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Preparation and Evaluation of Freeze-dried Solid Lipid Nanoparticles with Various Cryoprotectants

  • Published : 2010.02.20
Download PDF
⟨ Previous Next ⟩

Abstract

Solid lipid nanoparticles (SLNs) were freeze-dried to obtain a stable solid dosage form with the aid of various cryoprotectants such as trehalose, sucrose, glucose, fructose, and glycerol. Tricaprin(TC) and trilaurin(TL) were used as lipid matrices for SLNs and stabilizers were egg phosphatidylcholine and pegylated phospholipid. All cryoprotectants tested did not cause changes in mean particle size of SLNs when mixed with SLNs before freeze-drying. However, the mean particle sizes of reconstituted SLNs after freeze-drying were significantly different from those of the un-lyophilized original SLN dispersions depending on the types and concentration of cryoprotectants. Although the freeze-dried SLNs without any cryoprotectants were easily reconstituted by hand-shaking, the mean particle size drastically increased (> $8\;{\mu}m$ for TC SLNs and around $1\;{\mu}m$ for TL SLNs) compared to that of un-lyophilized original dispersion (97 nm for TC SLNs and 164 nm for TL SLNs). Trehalose and sucrose were the most effective additives to protect the SLNs during lyophilization. The reconstituted SLNs were physically stable for 24 hours when lyophilized with 12.5% trehalose, sucrose, glucose, fructose or glycerol.

Keywords

References

  1. P.D.Marcato and N. Duran, New aspects of nanopharmaceutical delivery systems, J. Nanosci. Nanotechnol., 8, 2216-29 (2008). https://doi.org/10.1166/jnn.2008.274
  2. D. Law, W. Wang, E.A. Schmitt, Y. Qiu, S.L. Krill, and J.J.Fort, Properties of rapidly dissolving eutectic mixtures of poly (ethylene glycol) and fenofibrate: the eutectic microstructure, J. Pharm. Sci. 92, 505-515 (2003). https://doi.org/10.1002/jps.10324
  3. M.D. Josh and R.H. Muller, Lipid nanoparticles for parenteral delivery of actives, Eur. J. Pharm. 71, 161-72 (2008). https://doi.org/10.1016/j.ejpb.2008.09.003
  4. C. Freitas and R.H. Muller, Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles ($SLN^{TM}$) dispersion, Int. J. Pharm. 168, 221-229 (1998). https://doi.org/10.1016/S0378-5173(98)00092-1
  5. B. Siekmann and K. Westesen, Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1, 123-126 (1992).
  6. C. Schwartz, J.S. Mehnert, J.S. Lucks, R.H. Muller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization, J. Control. Rel. 30, 83-96. (1994). https://doi.org/10.1016/0168-3659(94)90047-7
  7. C. Schwartz and W. Mehnert, Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN), Int. J. Pharm, 157, 171-179 (1997). https://doi.org/10.1016/S0378-5173(97)00222-6
  8. Y.N.Konan, R. Gurny, and E. Allermann, Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles, Int. J. Pharm. 354, 242-247 (2002) https://doi.org/10.1016/j.ijpharm.2007.10.049
  9. M.G. Anhorn, H.C. Mahler, K. Langer, Freeze-drying of human serum albumin (HSA) nanoparticles with different excipients, Int. J. Pharm. 363, 162-169 (2008). https://doi.org/10.1016/j.ijpharm.2008.07.004
  10. A.C.Bach, J. Ferezou, and A. Frey, Phospholipid-rich particles in commercial parenteral fat emulsions. An overview, Prog. Lipid Res. 35, 133-53 (1996) https://doi.org/10.1016/0163-7827(96)00001-X
  11. M. Ausborn, P. Nuhn, P. and H. Schreier, Stabilization of liposomes by freeze-thaw and lyophilization techniques: problems and opportunities, Eur. J. Pharm. Biopharm. 38, 133-139 (1992).
  12. G. Strauss, P. Schurtenberger, P. and H. Hauser, The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying, Biochim. Biophys. Acta. 858, 169-180 (1986). https://doi.org/10.1016/0005-2736(86)90303-2
  13. M. Grit and D.J.A. Crommelin, The effect of aging on the physical stability of liposome dispersions, Chem. Phys. Lipids. 62, 113-122. (1992). https://doi.org/10.1016/0009-3084(92)90089-8
  14. M.F. Powell, T. Nguyen and L. Baloian, Compendium of excipients for parenteral formulations, PDA J. Pharm. Sci. Tech. 52, 238-311 (1998).
  15. L. Zhang, L. liu, Y. Qian, and Y. Chen, The effect of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM), Eur. J. Pharm. Biopharm. 69, 750-759 (2008). https://doi.org/10.1016/j.ejpb.2007.12.003
  16. H. Ohshima, A. Migagishima, T. Kurita, Y. Makino, Y. Iwao, T. Sonobe and S. Itai, Freeze-dried nifedifine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution, Int. J. Pharm. 377, 180-184 (2008). https://doi.org/10.1016/j.ijpharm.2009.05.004
  17. S. Kamiya, T. Kurita, A. Miyagishima and M. Arakawa, Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols, Drug Dev. Ind. Pharm. 38, 1022-8 (2009). https://doi.org/10.1080/03639040802698786
  18. A. Misra, K. Jinturkar, D. Patel, J. Lalani and M. Chougule, recent advances in liposomal dry powder formulations: preparation and evaluation, Expert Opin. Drug Deliv. 6, 71-89 (2009). https://doi.org/10.1517/17425240802652309